Amundi Asset Management US’s Agios Pharmaceuticals AGIO Stock Holding History

Amundi Asset Management US’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$346K	Hold	6,700	–	–	﹤0.01%	1383
2020 Q4	$290K	Hold	6,700	–	–	﹤0.01%	1379
2020 Q3	$235K	Sell	6,700 -200	-3%	-$8.77K	﹤0.01%	1371
2020 Q2	$369K	Sell	6,900 -100	-1%	-$4.63K	﹤0.01%	1294
2020 Q1	$248K	Buy	7,000 +2,400	+52%	+$111K	﹤0.01%	1298
2019 Q4	$220K	Hold	4,600	–	–	﹤0.01%	1445
2019 Q3	$149K	Sell	4,600 -102,534	-96%	-$4.24M	﹤0.01%	1517
2019 Q2	$5.34M	Sell	107,134 -35,916	-25%	-$1.92M	﹤0.01%	935
2019 Q1	$9.65M	Buy	143,050 +138,850	+3,306%	+$8.09M	0.01%	723
2018 Q4	$193	Sell	4,200 -5,200	-55%	-$321K	﹤0.01%	1395
2018 Q3	$725K	Buy	+9,400	New	+$756K	﹤0.01%	1308

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amundi Asset Management US's AGIO Position: Q1 2021 in Review

Amundi Asset Management US held its Agios Pharmaceuticals (AGIO) position steady in Q1 2021 at 6,700 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Amundi Asset Management US first reported a position in AGIO in Q3 2018 and has held it in 11 quarters since. The position peaked at $9.65M in Q1 2019. 175 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

Amundi Asset Management US held 6,700 shares of Agios Pharmaceuticals worth $346K as of Q1 2021.
Amundi Asset Management US left its Agios Pharmaceuticals share count unchanged in Q1 2021.
Agios Pharmaceuticals made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1383 holding.
Amundi Asset Management US first reported a position in Agios Pharmaceuticals in Q3 2018 and has held it in 11 quarters since.
Amundi Asset Management US's Agios Pharmaceuticals position peaked at $9.65M in Q1 2019.
175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.